Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Premiered Apr 1, 2020
👇KEY POINTS OF INTEREST 02:55 What would happen if China stopped all drug exports? 04:53 Why is Big Pharma lobbying against a “Buy American” executive order? 11:29 The terrible, hidden costs of having global supply chains in China for medicines 22:06 Pharmaceutical companies are unwilling to explain where their products are made 27:56 “The free market will not fix this” because Chinese companies are massively subsidized. 31:13 The US must rebuild its manufacturing capability for medicines
How is it possible that the global supply of medicine components is almost entirely controlled by China?
How is this being used as leverage against other countries, especially the U.S.? What would happen if China decided to stop exporting drug ingredients, especially now, during the CCP virus, or coronavirus outbreak?
Why are special interests like Big Pharma lobbying against a potential “Buy American” executive order?
Is it possible that medicines manufactured in the US could actually be produced cheaper than using global supply chains, as most are today?
In this episode, we sit down with Rosemary Gibson, senior advisor at the Hastings Center and author of “China Rx: Exposing the Risks of America's Dependence on China for Medicine.”
This is American Thought Leaders 🇺🇸, and I’m Jan Jekielek.